University of Washington Center for Cannabis Research
(UW CCR)

Some task force members sought input from WSLCB and DOH guests on how to proceed with hemp consumable legislation given that THC regulations were already undergoing revisions.

Members and agency staff provided praise and criticism of research articles put forward by staff involving “Regulatory Science,” cannabinoid differences, testing results, and terminology.

Bills to restrict cannabis concentrates had the support of some health officials and an anti-legalization group, but industry members and a consumer advocate tagged them “prohibition bill[s]."

After failing to reach consensus on hemp product THC limits in their final report, it became clear that input from WSDA wouldn’t address the issue for subsequent industry-led legislation either.

The principal researcher responsible for organizing the high THC cannabis symposium and delivering the policy report presented their findings from surveys of recruited stakeholders.

Task force members discussed drafting their report due to the legislature on December 1st before talking about what cannabinoid limits they’d recommend for hemp in food.

The chair of the WA House cannabis policy committee commented on her background as well as legislative concerns and strategies she expected to hear during the 2023 session.

Three Democratic state legislators shared their views on research and pushing legislation around cannabis products with high cannabinoid concentrations, if re-elected.

A WSU researcher described results of two studies she conducted on cannabis consumption and memory, sharing that her hypothesis on the impacts of concentrates hadn’t been validated.

UW ADAI leaders opened the day-long event by claiming revised regulation of cannabis concentrates would establish the state as a wise “big brother” learning from legalization.